1. DOP74 Comparative effectiveness of vedolizumab and ustekinumab in Crohn's Disease patients who failed anti-TNF treatment: Interrogating 1019 patients from the UK IBD BioResource. (21st January 2022) Authors: Desoki, R; Balendran, K; Kapizioni, C; Shawky, R; Parkes, M; Raine, T Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P151 Rationalizing colonoscopy utilization for Inflammatory bowel disease diagnosis: time to reset the Calprotectin threshold to >600?. (21st January 2022) Authors: Desoki, R; Abdellah Ahmed, M; Taylor, K; Woodward, J; Corbett, G; Parkes, M Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P668 Differential efficacy of biologic agents for Inflammatory Bowel Disease Unclassified and comparison with Ulcerative Colitis: a propensity score analysis of 4054 patients from the UK IBD BioResource. (30th January 2023) Authors: Kapizioni, C; Desoki, R; Balendran, K; Lam, D; Shawky, R; Pele, L; Parkes, M; Raine, T Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i800 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗